FDA Officials Question Lack of New Cancer Drugs Developed in Combination With Radiation
By Zachary Brennan -
Published 13 April 2017
Although almost half of patients with cancer who are cured will have received radiation therapy as a component of their care, there is still a dearth of new therapies being developed in combination with radiation, officials from the US Food and Drug Administration (FDA) wrote in an article published this week.
Categories: News, US, FDA, Biologics and biotechnology, Combination products, Drugs, Due Diligence, Regulatory intelligence, Regulatory strategy
Tags: hematology and oncology, radiation therapy, cancer drugs